Advertisement

Metabolic Brain Disease

, Volume 3, Issue 3, pp 211–216 | Cite as

Inhibitory neuromodulators do not alter the course of experimental hepatic encephalopathy

  • David Rzepczynski
  • Leslie Zieve
  • Sandra Lindblad
Original Contributions

Abstract

The neuromodulators, adenosine, serotonin, and glycine, did not alter the course of hepatic encephalopathy (HE) that followed a portacaval shunt and hepatic artery ligation in rats. The substances were instilled into the brain ventricle through an intraventricular cannula in doses that affect other aspects of behavior in the normal rat (adenosine, suppression of food intake; serotonin, loss of muscle strength and ataxia; glycine, leaning and circling). A subconvulsive dose of the glycine antagonist, strychnine, also had no effect on the course of HE. A large dose of the adenosine antagonist, caffeine, had a depressive rather than excitatory effect and shortened the time taken to induction of coma. These studies and a similar previous one with γ-aminobutyric acid (GABA) suggest that the inhibitory neuromodulators do not have a prominent role in the pathogenesis of hepatic coma.

Key words

adenosine caffeine glycine hepatic encephalopathy neuromodulators serotonin strychnine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Borg, J., Warter, J. M., Schlienger, J. L., Imler, M., Marescaux, C., and Mack, G. (1982). Neurotransmitter modifications in human cerebrospinal fluid and serum during hepatic encephalopathy.J. Neurol. Sci. 57: 343–356.Google Scholar
  2. Bugge, M., Bengtsson, F., Nobin, A., Jeppsson, B., and Herlin, P. (1986). Metabolism of monoamine in the brain after total hepatectomy in the rat.Exp. Neurol. 94: 11–20.Google Scholar
  3. Bugge, M., Bengtsson, F., Nobin, A., Jeppsson, B., and Herlin, P. (1987). The effect of liver ischemia on brain monoamine synthesis in the rat.Res. Exp. Med. 187: 119–130.Google Scholar
  4. Cummings, M. G., James, J. H., Soeters, P. B., Keane, J. M., Foster, J., and Fischer, J. E. (1976). Regional brain study of indoleamine metabolism in the rat in acute hepatic failure.J. Neurochem. 27: 741–746.Google Scholar
  5. Curzon, G., and Knott, P. J. (1977). Environmental, toxicological, and related aspects of tryptophan metabolism with particular reference to the central nervous system.CRC Crt. Rev. Toxicol. Sept: 145–187.Google Scholar
  6. Feldberg, W., and Sherwood, S. L. (1954). Injection of drugs into the lateral ventricle of the cat.J. Physiol. 123: 148–167.Google Scholar
  7. Ferenci, P., Pappas, S. C., Munson, P. J., Henson, K. and Jones, E. A. (1984). Changes in the status of neurotransmitter receptors in a rabbit model of hepatic encephalopathy.Hepatology 4: 186–191.Google Scholar
  8. Fischer, J. E., James, J. H., and Baldessarini, R. (1972). Changes in brain amines following portal flow diversion and acute hepatic coma: Effects of levodopa (L-Dopa) and intestinal sterilization.Surg. Forum 23: 348–350.Google Scholar
  9. Giges, B., Dein, H. L., Sborov, V. M., Seligson, D., and Howard, J. M. (1953). Experimental hepatic coma.Surg. Gynec. Obstet. 97: 763–768.Google Scholar
  10. Knell, A. J., Davidson, A. R., Williams, R., Kantamaneni, B. D., and Curzon, G. (1974). Dopamine and serotonin metabolism in hepatic encephalopathy.Brit. Med. J. 1: 549–551.Google Scholar
  11. Levine, A. S., and Morley, J. E. (1983). Effect of intraventricular adenosine on food intake in rats.Pharmacol. Biochem. Behav. 19: 23–26.Google Scholar
  12. Mattson, W. J., Jr., and Turcotte, J. G. (1969). Survival and metabolism in experimental endogenous hepatic coma.Surg. Gynec. Obstet. 128: 557–564.Google Scholar
  13. Patel, J., Marangos, P. J., and Boulenger, J. P. (1984). Adenosine: Its action and sites of action in the CNS. InBrain Receptor Methodologies. Part B, Academic Press, New York, pp. 297–325.Google Scholar
  14. Pycock, C. J., and Kerwin, R. W. (1981). The status of glycine as a supraspinal neurotransmitter.Life Sci. 28: 2679–2686.Google Scholar
  15. Rappaport, A. M., and Lotto, W. N. (1951). Experimental hepatic coma.Proc. Soc. Exp. Biol. Med. 78: 14–15.Google Scholar
  16. Rzepczynski, D., Zieve, L., Lindblad, S., and LaFontaine, D. (1986).In vivo studies of GABAergic effects in experimental hepatic encephalopathy.Hepatology 6: 902–905.Google Scholar
  17. Young, A. B., and Snyder, S. H. (1973). Strychnine binding associated with glycine receptors in the central nervous system.Proc. Natl. Acad. Sci. 70: 2832–2836.Google Scholar
  18. Zieve, L., Ferenci, P., Rzepczynski, D., Ebner, J., and Zimmerman, Ch. (1987). A benzodiazepine antagonist does not alter the course of hepatic encephalopathy or neural γ-aminobutyric acid (GABA) binding.Metab. Brain Dis. 2: 201–205.Google Scholar

Copyright information

© Plenum Publishing Corporation 1988

Authors and Affiliations

  • David Rzepczynski
    • 1
  • Leslie Zieve
    • 1
  • Sandra Lindblad
    • 1
  1. 1.VA and Hennepin County Medical CentersUniversity of MinnesotaMinneapolis

Personalised recommendations